It is rare, then, that a single kinase is commonly mutated (with the well-known exception, BRAF, which is mutated in over 60% of melanoma cases),58 suggesting that several infrequently mutated kinases most likely contribute to tumorigenesis and progression. This evidence concerns the gene BRAF and melanoma.